| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/06/1997 | WO1997008300A1 Crystalline zap family proteins |
| 03/06/1997 | WO1997008182A1 Process for the preparation of imidazolyl macrolide immunosuppressants |
| 03/06/1997 | WO1997008166A1 Piperazino derivatives as neurokinin antagonists |
| 03/06/1997 | WO1997008133A1 Amide compounds and use of the same |
| 03/06/1997 | WO1997007823A2 Compositions and their uses |
| 03/06/1997 | WO1997007791A1 Use of aminoadamantane compounds as immunoregulators |
| 03/06/1997 | CA2502764A1 Amide compounds |
| 03/06/1997 | CA2229844A1 Compositions and their uses |
| 03/06/1997 | CA2229718A1 Process for the preparation of imidazolyl macrolide immunosuppressants |
| 03/06/1997 | CA2226963A1 Crystalline zap family proteins |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759937A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 03/05/1997 | EP0759934A1 Neurotensin antagonist peptides |
| 03/05/1997 | EP0759930A1 Chimeric mhc class i antigens for inducing allograft tolerance |
| 03/05/1997 | EP0759922A1 New antagonist compounds |
| 03/05/1997 | EP0759777A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
| 03/05/1997 | EP0759775A1 IFN-$g(b) LIQUID FORMULATIONS |
| 03/05/1997 | EP0759771A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
| 03/05/1997 | EP0759766A1 EXTRACTS OF $i(STEPHANIA TETRANDRA) FOR INHIBITION OF INTERLEUKIN-6 PRODUCTION |
| 03/05/1997 | EP0759759A1 P75 tnf receptor promoters |
| 03/05/1997 | EP0759758A1 Sialic acid/fucose based medicaments |
| 03/05/1997 | EP0759751A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same |
| 03/05/1997 | EP0623122B1 Benzopyran and related LTB4-antagonists. |
| 03/05/1997 | EP0620809B1 $g(a)-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES |
| 03/05/1997 | CN1144091A Compounds having retinoid-like activity |
| 03/05/1997 | CN1034175C Pyrazolopyrimidines compound |
| 03/04/1997 | US5608095 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 03/04/1997 | US5608038 Highly concentrated immunoglobulin preparation and method for its production |
| 03/04/1997 | US5607978 Prostaglandins for vision defects |
| 03/04/1997 | US5607936 Useful in treatment of respiratory diseases |
| 03/04/1997 | US5607846 Vaccine for moraxella catarrhalis |
| 03/04/1997 | US5607675 Treatment of autoimmune diseases with IL-2 receptor-specific cytotoxin |
| 02/27/1997 | WO1997007404A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | WO1997007232A1 Antigenic preparations |
| 02/27/1997 | WO1997007218A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997006826A1 Gene therapy using ovine adenoviral vectors |
| 02/27/1997 | WO1997006790A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | DE19531342A1 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 02/27/1997 | CA2229938A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229135A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | CA2227795A1 Allergen-xcd32 fusion proteins |
| 02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 02/26/1997 | EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 02/26/1997 | EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 02/26/1997 | EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 02/26/1997 | EP0541753B1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT |
| 02/26/1997 | CN1143963A Tetracyclic derivatives, process of preparation and use |
| 02/26/1997 | CN1143956A 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing same and their use as medicaments |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1143497A Method of treating cardiac inflammatory disease |
| 02/25/1997 | US5606065 Antagonist of neurokinin receivers |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605924 Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes |
| 02/25/1997 | US5605923 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 02/25/1997 | US5605825 Human PAK65 |
| 02/25/1997 | US5605821 Expression control sequences of the P-selectin gene |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605688 Recombinant dog and horse type I interferons |
| 02/25/1997 | CA1338948C Composition for macrophage activation |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006241A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | WO1997005900A1 Cell derived antigen presenting vesicles |
| 02/20/1997 | WO1997005896A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
| 02/20/1997 | WO1997005878A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005877A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005859A2 Use of alicyclic diamines as immunomodulators |
| 02/20/1997 | WO1996040260A3 Immunotoxins specific for cd80 and cd86 expressing cells |
| 02/20/1997 | WO1996040081A3 Oral delivery of gene constructs |
| 02/20/1997 | WO1996039147A3 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases |
| 02/20/1997 | CA2228689A1 Use of alicyclic diamines as immunomodulators |
| 02/20/1997 | CA2228379A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
| 02/20/1997 | CA2228136A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2228050A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2227584A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | CA2225553A1 Cell derived antigen presenting vesicles |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758656A2 Immunoglobulin activated by mixing with a histamine component |
| 02/19/1997 | EP0758648A1 Substituted 4H-pyrans with a modulating effect on calcium channels |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758387A1 Thymidine kinase mutants |
| 02/19/1997 | EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 02/19/1997 | EP0758340A1 Process for the preparation of 4-amino-delta 4-3-ketosteroids via 4-nitro-delta 4-3-ketosteroids |
| 02/19/1997 | EP0758328A1 Anti-cancer compounds containing cyclopentaquinazoline ring |
| 02/19/1997 | EP0758243A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa |
| 02/19/1997 | EP0758239A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them |
| 02/19/1997 | EP0758238A1 Spiro-substituted azacycles as neurokinin-3 antagonists |
| 02/19/1997 | EP0758232A1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 02/19/1997 | EP0654026B1 Isoserine derivatives and their use as leukotriene antagonists |
| 02/19/1997 | EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof |